Portfolio Design Labs’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Portfolio Design Labs's BMY Position: Q2 2026 in Review
Portfolio Design Labs increased its Bristol-Myers Squibb (BMY) stake by 0.42% in Q2 2026, buying an estimated $2.99K and bringing the position to 12,294 shares worth $708K. The position accounts for 0.12% of the portfolio, ranked #140.
Portfolio Design Labs first reported a position in BMY in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.08M in Q1 2025. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Portfolio Design Labs held 12,294 shares of Bristol-Myers Squibb worth $708K as of Q2 2026.
- Portfolio Design Labs bought 52 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.99K.
- Bristol-Myers Squibb made up 0.12% of Portfolio Design Labs's portfolio in Q2 2026, its #140 holding.
- Portfolio Design Labs first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 8 quarters since.
- Portfolio Design Labs's Bristol-Myers Squibb position peaked at $3.08M in Q1 2025.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.